On-demand Webcast

Share

Program Content

Activities

  • Precision Therapeutics in NF1 Associated Tumors
    Precision Therapeutics for NF1-Associated Tumors: Improved Outcomes Through Targeted MEK Inhibition
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 24, 2024

    Expires: June 23, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.

Alexion Pharmaceuticals

SpringWorks Therapeutics, Inc.